Effect of protease inhibitors on peptide-stimulated amylase secretion from dispersed pancreatic acini
Tóm tắt
Cholecystokinin (CCK) and bombesin stimulate dose-dependent amylase secretion from dispersed pancreatic acini. To establish whether cellular proteases can reduce secretion by degrading these regulatory peptides, the effect of protease inhibition on CCK and bombesin stimulated amylase secretion was investigated. A spectrum of protease inhibitors, including bacitracin, phenylmethylsulfonylfluoride, captopril, bestatin, phosphoramidon, and 1,10-phenanthroline, were investigated. Bacitracin (0.35 mM) increased the acinar amylase secretory response to CCK and bombesin substantially, suggesting that these two peptides are degraded by an endopeptidase from pancreatic acinar cells. In contrast, PMSF (1 mM) inhibited CCK and bombesin stimulated amylase release, suggesting a covalent interaction with this inhibitor and CCK or bombesin receptors. Other protease inhibitors either had minimal or no effects on acinar cell secretion. These results suggest bacitracin is a valuable enzyme inhibitor that can potentiate the effect of CCK and bombesin on acinar cells. In contrast, PMSF should be avoided when using these secretagogs to study pancreatic function.
Tài liệu tham khảo
Cantor P. Cholecystokinin in plasm.Digestion 1989; 42: 181–201.
Morley JE. The ascent of cholecystokini (CCK) from gut to brain.Life Sci 1982; 30: 479–493.
Thompson JC, Marx M. Gastrointestinal hormones. Vol. 21. Ravich MM and Steichen FM, eds.Current Problems in Surgery. Year Book Medical Publisher, Inc., Chicago, IL, 1984, 1–80.
McDonald TJ, Jornvall H, Nilsson G, Vagne M, Ghatei M, Bloom R, Mutt V. Characterization of gastrin releasing peptide from porcine non-antral gastric tissue.Biochem Biophys Res Commun 1979; 90: 227–233.
Minamino N, Kangawa K, Matsuo H. Neuromedin C: a bombesin-like peptide identified in porcine spinal cord.Biochem Biophys Res Commun 1984; 119: 14–17.
Ghatei MA, Jung RT, Stevenson JC, Hillyard CJ, Adrian TE, Lee Y, Christofides ND, Sarson DL, Mashiter K, Macintyre I, Bloom SR. Bombesin action on gut hormones and calcium in man.J Clin Endocrinol Metab 1982; 54: 980–985.
Cuttitta F, Carney N, Mulshine J, Moody TW, Fedorko J, Fischler A, Minna JD. Bombesin-like peptides can function as autocrine growth factors in human small cell lung cancer.Nature (Lond) 1985; 318: 823–826.
Nelson J, Donnelly M, Walker B, Gray J, Shaw C, Murphy RF. Bombesin stimulates proliferation of human breast cancer cells in culture.Br J Cancer 1991; 63: 933–936.
Avis FP, Maneckjee R, Cuttitta F, Nakanishi Y, Mulshine J, Avis I. The role of gastrin releasing peptide in a pancreatic tumor cell line (CAPAN).Pro AACR 1988; 29: 54.
Wang WJ, Knezetic JA, Schally AV, Pour PM, Adrian TE. Gastrin releasing peptide is an autocrine growth factor in human pancreatic cancer.Gastroenterology 1994; 106: A849.
Matozaki T, Williams JA. Multiple sources of 1,2-diacyl-glycerol in isolated rat pancreatic acini stimulated by cholecystokinin.J Biol Chem 1989; 264: 14729–14734.
Uhlemann ER, Rottman AJ, Gardner JD. Actions of peptides isolated from amphibian skin on amylase release from dispersed pancreatic acini.Am J Physiol 1979; 236: E571-ES76.
Bauvois B, Gavrilovic J, Wietzerbin J. Localizations and potential roles of leukocyte proteases. Breeih S, Ezine S, and Imhof B. eds.Lymphatic Tissues and In Vivo Immune Responses. Marcel Dekker, New York, 1991, 259–265.
Bunnett NW. Release and breakdown. Postsecretory metabolism of peptides.Am Rev Respir Dis 1987; 136: S27-S34.
Bunnett NM, Kobayashi R, Orloff MS, Reeve JR, Turner AJ, Walsh JH. Catabolism of gastrin releasing peptide and substance P by gastric membrane bound peptidases.Peptides 1985; 6: 277–283.
Matsas R, Turner AJ, Kenny AJ. Endopeptidase 24.11 and aminopeptidase activity in brain synaptic membranes are jointly responsible for the hydrolysis of cholecystokinin octapeptide (CCK8).FEBS Lett 1984; 175: 124–128.
Bunnett NW, Debas HT, Turner AJ, Kobayashi R, Walsh JH. Metabolism of gastrin and cholecystokinin by endopeptidase 24.11 from the pig stomach.Am J Physiol 1988; 255: G676-G684.
Deschodt-Lanckman M, Bui ND, Koulischer D, Proutaud P, Strosberg AD. Cholecystokinin octa- and tetrapeptide degradation by synaptic membranes. II. Solubilization and separation of membrane bound CCK-8 cleaving enzymes.Peptides 1983; 4: 71–78.
Kerr MA, Kenny AJ. The purification and specificity of a neutral endopeptidase from rabbit kidney brush border.Biochem J 1974; 137: 477–488.
Erdös EG, Skidgel RA. Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones.FASEB J 1989; 6: 145–152.
Raynaud F, Bauvois B, Gerbaud P, Evain-Brion D. Characterization of specific proteases associated with the surface of human skin fibroblasts, and their modulation in pathology.J Cell Physiol 1992; 151: 378–385.
Kato T, Nagatsu T, Fukasawa K, Harando M, Nagatsu I, Sakakibara S. Suceessive cleavage of N-terminal Argl-Pro2 and Lys3-Pro4 from substance P but no release of Arg1-Pro2 from bradykinin by X-Pro dipeptidyl aminopeptidase.Biochim Biophys Acta 1978; 525: 417–422.
Terashima H, Okamoto A, Menozzi D, Goetzi EJ, Bunnett NW. Identification of neuropeptide-degrading enzymes in the pancreas.Peptides 1992; 13: 741–748.
Semenza G. Anchoring and biosynthesis of stalked brush border membrane proteins: Glycosidases and peptidases of enterocytes and renal tubuli.Annu Rev Cell Biol 1986; 2: 255–313.
Taylor A. Aminopeptidases: structure and function.FASEB J 1993; 7: 290–298.
Umezawa H, Aoyagi T, Suda H, Hamada M, Takeuchi TJ, Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes.J Antibiot 1976; 29: 97–99.
Harbeson SL, Rich DH. Inhibition of arginine aminopeptidase by bestatin and arphamenine analogues. Evidence for a new mode of binding to aminopeptidases.Biochemistry 1988; 27: 7301–7310.
Schulz GS, Sarras MP, Gunther GR, Hull BE, Alicea HA, Gorelick FS, Jamieson JD. Guinea pig pancreatic acini prepared with purified collagenase.Exp Cell Res 1980; 130: 49–62.
Adrian TE, Zucker KA, Bilchik AJ, Modlin IM. A novel micromethod for pancreatic secretion.Int J Pancreatol 1990; 6: 61–69.
Ceska M, Birath K, Brown B. A new and rapid method for the clinical determination of amylase activities in human serum and urine.Clin Chim Acta 1969; 26: 437–444.
Hawcock AB, Barnes JC, Michel AD. Pharmacological characterization of angiotensin-induced depolarization of rat superior cervical ganglion in vitro.Br J Pharmacol 1992; 105: 686–690.
Land T, Langel U, Bartfai T. Hypothalamic degradation of galanin(1–29) and galanin(1–16): identification and characterization of the peptidyllytic products.Brain Res 1991; 558: 245–250.
Lucius R, Mentlein R. Degradation of the neuropeptide somatostatin by cultivated neuronal and glial cells.J Biol Chem 1991; 266: 18907–18913.
Hosotani R, Chowdhury P, Doi R, Rayford PL. Characterization of interactions between CCK-33 and CCK receptors in isolated dispersed pancreatic acini.J Cell Physiol 1992; 153: 523–527.
Markwardt F, Walsmann P, Hoffmann J. Influence of synthetic protease inhibitors on the effect and activation of proteolytic enzymes of the pancreas.Acta Biol Med Ger 1974; 32: 433–443.
Blow DM. Enzyme substrate and inhibitor interactions.Phil Trans R Soc Lond 1975; 272: 87–97
Kraut J. Serine proteases: structure and mechanism of catalysis.Ann Rev Biochem 1977; 46: 331–358.
Laura R, Robison DJ, Bing DH. (p-Aminophenyl) methanesulfonyl fluoride, an irreversible inhibitor of serine proteases.Biochemistry 1980; 19: 4859–4864.
Brtko J, Knopp J, Baker ME. Inhibition of 3,5,3′-triiodothyronine binding to its receptor in rat liver by protease inhibitors and substrates.Mol Cell Endocrinol. 1993; 93: 81–86.